These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33528955)

  • 41. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of botulinum toxin therapy in treatment of myofascial pain.
    Chaurand J; Pacheco-Ruíz L; Orozco-Saldívar H; López-Valdés J
    J Oral Sci; 2017; 59(3):351-356. PubMed ID: 28904310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Temporomandibular Myofacial Pain Treated with Botulinum Toxin Injection.
    Mor N; Tang C; Blitzer A
    Toxins (Basel); 2015 Jul; 7(8):2791-800. PubMed ID: 26213970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of injection of botulinum toxin on lateral pterygoid muscle used together with the arthroscopy in patients with anterior disk displacement of the temporomandibular joint.
    Arinci A; Güven E; Yazar M; Başaran K; Keklik B
    Kulak Burun Bogaz Ihtis Derg; 2009; 19(3):122-9. PubMed ID: 19857189
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum Toxin Type A for Painful Temporomandibular Disorders: Systematic Review and Meta-Analysis.
    Machado D; Martimbianco ALC; Bussadori SK; Pacheco RL; Riera R; Santos EM
    J Pain; 2020; 21(3-4):281-293. PubMed ID: 31513934
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of Localized and Referred Masticatory Myofascial Pain with Botulinum Toxin Injection.
    Montes-Carmona JF; Gonzalez-Perez LM; Infante-Cossio P
    Toxins (Basel); 2020 Dec; 13(1):. PubMed ID: 33374687
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bruxism, temporo-mandibular dysfunction and botulinum toxin].
    Chikhani L; Dichamp J
    Ann Readapt Med Phys; 2003 Jul; 46(6):333-7. PubMed ID: 12928140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurogenic temporomandibular joint dislocation treated with botulinum toxin: report of 4 cases.
    Vázquez Bouso O; Forteza González G; Mommsen J; Grau VG; Rodríguez Fernández J; Mateos Micas M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e33-7. PubMed ID: 20219583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders.
    Plesh O; Curtis D; Levine J; McCall WD
    J Oral Rehabil; 2000 Oct; 27(10):834-41. PubMed ID: 11065017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Botulinum toxin used to treat recurrent dislocation of the temporomandibular joint in a patient with osteoporosis.
    Oztel M; Bilski WM; Bilski A
    Br J Oral Maxillofac Surg; 2017 Jan; 55(1):e1-e2. PubMed ID: 27256802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Temporomandibular disorders in patients with craniocervical dystonia.
    Costa AL; Campos LS; França MC; D'Abreu A
    Arq Neuropsiquiatr; 2011 Dec; 69(6):896-9. PubMed ID: 22297875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum Neurotoxin Injection for the Treatment of Recurrent Temporomandibular Joint Dislocation with and without Neurogenic Muscular Hyperactivity.
    Yoshida K
    Toxins (Basel); 2018 Apr; 10(5):. PubMed ID: 29693593
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 55. Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials.
    Chen YW; Chiu YW; Chen CY; Chuang SK
    Int J Oral Maxillofac Surg; 2015 Aug; 44(8):1018-26. PubMed ID: 25920597
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System.
    Bogucki ZA; Kownacka M
    Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
    Laskin DM
    J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023
    [No Abstract]   [Full Text] [Related]  

  • 58. Botulinum toxin injection for management of temporomandibular joint clicking.
    Emara AS; Faramawey MI; Hassaan MA; Hakam MM
    Int J Oral Maxillofac Surg; 2013 Jun; 42(6):759-64. PubMed ID: 23538215
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyoid bone syndrome masquerading as temporomandibular joint dysfunction.
    Jose A; Nagori SA; Arya S; Roychoudhury A
    Br J Oral Maxillofac Surg; 2019 Jun; 57(5):477-478. PubMed ID: 31054794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of somatization, depression, and chronic pain with clinical findings of the temporomandibular disorders in asymptomatic women.
    Jeremic-Knezevic M; Knezevic A; Boban N; Djurovic Koprivica D; Boban J
    Cranio; 2021 Jan; 39(1):17-23. PubMed ID: 30537909
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.